Print

AcelRx Pharmaceuticals (ACRX) Reports Second Quarter 2013 Financial Results  
8/13/2013 6:14:44 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

REDWOOD CITY, Calif., Aug. 12, 2013 /PRNewswire via COMTEX/ -- AcelRx Pharmaceuticals, Inc. /quotes/zigman/3905437/quotes/nls/acrx ACRX -2.70% , ("AcelRx"), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, today reported financial results for the three and six months ended June 30, 2013.

Hey, check out all the research scientist jobs. Post your resume today!

//-->